Alleviant ALLAY-HF Study

Enrolling by invitation · Not applicable · Has a placebo group

Conditions studied: Heart Failure

In brief

Prospective, multicenter, randomized, sham-controlled, double blinded, adaptive study designed to evaluate the safety and efficacy of a percutaneously created interatrial shunt using the Alleviant ALV1 System in patients with HFpEF/HFmrEF.

Key facts

Study ID
NCT05685303
Run by
Alleviant Medical, Inc.
People needed
700
Starts
2023-01-10
Expected to finish
2032-12-01
Last updated by the study team
2026-05-04

Who can join

Age: 40 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.